Five Questions For … Austin Biotech Entrepreneur Paul Lammers | Angela Shah | 09/29/17 | Texas |
Houston Biotech Oncolix Announces Reverse Merger, Goes Public | Angela Shah | 08/07/17 | Texas |
Acer Therapeutics Announces Reverse Merger With Houston’s Opexa | Angela Shah | 07/05/17 | Texas |
Synlogic and Its Modified Bacteria Take Over Dying Company, Go Public | Alex Lash | 05/16/17 | Boston |
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate | Angela Shah | 05/18/16 | Texas |
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations | Ben Fidler | 10/29/15 | San Francisco |
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO | Ben Fidler | 10/21/15 | Boston |
Voyager Charts an IPO Course Amid Choppy Biotech Waters | Ben Fidler | 10/11/15 | Boston |
Bio Slump Hits IPOs as Edge, Mirna Cut Prices, Upsize to Close Deals | Ben Fidler | 10/01/15 | New York |
Mirna Therapeutics Secures $44,100,000 New Financing | VentureDeal | 09/30/15 | Texas |
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO | Ben Fidler | 09/28/15 | San Francisco |
Verastem Sinks as Mesothelioma Study Halted For Futility | Ben Fidler | 09/28/15 | Boston |
Texas Roundup: Favor, UT-San Antonio, Yan Engines, Health Wildcatters | Angela Shah | 08/28/15 | Texas |
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO | Angela Shah | 08/24/15 | Texas |
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding | Angela Shah | 04/30/15 | Texas |
Mirna Therapeutics Lands $41,800,000 Series D Financing Round | VentureDeal | 04/30/15 | Texas |
New Funding, Commercialization Officer at Texas Cancer Agency | Angela Shah | 05/22/14 | Texas |
Mirna Therapeutics Taking on Cancer With Help of Tiny RNAs | Angela Shah | 07/09/13 | Texas |
Mirna Therapeutics Secures $34,500,000 Series C Funding Round | VentureDeal | 10/24/12 | Texas |
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs | Luke Timmerman | 12/12/11 | Seattle |
Mirna Therapeutics Secures $1,500,000 New Financing | VentureDeal | 08/23/11 | Texas |
Mirna Therapeutics Lands $25,000,000 New Financing Round | VentureDeal | 09/30/10 | Texas |
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names | Luke Timmerman | 08/16/10 | Seattle |
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash | Luke Timmerman | 04/26/10 | Seattle |